624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster II

National trends and demographic disparities in Hodgkin disease mortality across the United States 1999–2024

Immune checkpoint Inhibitors impact on outcomes of relapsed and refractory Hodgkin lymphoma A real world study

Effects of antibiotic prophylaxis in first line therapy of advanced stage classic Hodgkin lymphoma An analysis of the GHSG HD21 study

Rural urban disparities in survival rates in adult Hodgkin lymphoma A population based study

Smart start with tislelizumab as frontline treatment in advanced-stage classical Hodgkin lymphoma a PET adapted chemotherapy sparing phase 2 study

Relapsed Refractory Hodgkin lymphoma after first line escalated beacopdac Adverse outcomes are overcome by use of second line targeted therapy an international real world analysis

Inflammatory and oxidative stress biomarkers associated with cognitive function in patients with Hodgkin lymphoma treated with chemotherapy

Real world experience with brecadd protocol as frontline therapy for patients with advanced stage classical Hodgkin lymphoma A multicenter retrospective study